Drug Delivery System Based on CTAB/CS‐Modified Kanemite for Methotrexate and Its Cytotoxicity Against HepG2 Cells DOI Open Access

Yijun Liu,

Fang Guo,

Xiaoqiang Shang

et al.

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(38)

Published: Oct. 1, 2024

Abstract Cationic cetyltrimethylammonium (CTAB) is an effective and common intercalator for interlayered modification in layered materials, while its biotoxicity remains issue. To improve biosafety biocompatibility of the drug delivery system, nontoxic chitosan (CS) was introduced into CTAB‐modified kanemite (Ka‐CTAB). Accordingly, obtained Ka‐CTAB/CS further used as a carrier methotrexate (MTX). Various characterizations were employed to investigate system based on Ka‐CTAB/CS. Results revealed that loading capacity MTX about 13.47%, exhibited slow sustained release drugs either phosphate buffer solution (pH = 7.4) or HCl 1.35). The introduction CS not only replaced part CTAB composition but also prevented molecules falling off during drug‐releasing process. In methyl orange dye assay, concentration free shed from low 8.09 × 10 −7 mol/L after 24 h. vitro cell viability assay using HepG2 cells, lower cytotoxicity compared previous Ka‐CTAB.

Language: Английский

Emerging natural polymer-based architectured nanotherapeutics for the treatment of cancer DOI
K. KUNA, Sudhakar Reddy Baddam, Sudhakar Kalagara

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 262, P. 129434 - 129434

Published: Jan. 15, 2024

Language: Английский

Citations

17

Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery DOI

Wanfei Shao,

Yanfang Yang,

Weidong Shen

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 273, P. 132671 - 132671

Published: May 31, 2024

Language: Английский

Citations

11

Recent advances on chitosan/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: A comprehensive review DOI

Fahad Alsaikhan,

Bagher Farhood

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: unknown, P. 135893 - 135893

Published: Sept. 1, 2024

Language: Английский

Citations

8

Nanoarchitectonics of CTAB-modified kanemite as carrier of methotrexate DOI
Yufeng Chen,

Yijun Liu,

Xiaoqiang Shang

et al.

Applied Clay Science, Journal Year: 2024, Volume and Issue: 250, P. 107279 - 107279

Published: Jan. 30, 2024

Language: Английский

Citations

5

Improved physicochemical stability of fish oil nanoemulsion via a dense interfacial layer formed by hyaluronic acid-poly(glyceryl)10-stearate DOI
Sha Ao, Xiang Luo,

Hongze Wu

et al.

Food Chemistry, Journal Year: 2024, Volume and Issue: 444, P. 138585 - 138585

Published: Feb. 3, 2024

Language: Английский

Citations

4

Biopolymer-Based Tumor Microenvironment-Responsive Nanomedicine for Targeted Cancer Therapy DOI
Abhishek Jha, Manish Kumar, Kanchan Bharti

et al.

Nanomedicine, Journal Year: 2024, Volume and Issue: 19(7), P. 633 - 651

Published: March 1, 2024

Nanomedicine has opened up new avenues for cancer treatment by enhancing drug solubility, permeability and targeted delivery to cells. Despite its numerous advantages over conventional therapies, nanomedicine may exhibit off-target distribution, harming nontarget regions. The increased permeation retention effect of in tumor sites also limitations, as abnormal vasculature, dense stroma structure altered microenvironment (TME) result limited intratumor distribution therapeutic failure. However, TME-responsive exhibited immense potential efficient, safe precise therapeutics utilizing stimuli specific the TME. This review discusses mechanistic aspects various biopolymers their application developing types nanomedicine.

Language: Английский

Citations

4

Recent advances of hyaluronic acid‐based materials in drug delivery systems and regenerative medicine: A review DOI

Mohamed J. Saadh,

Hanan Hassan Ahmed,

Radhwan Abdul Kareem

et al.

Archiv der Pharmazie, Journal Year: 2025, Volume and Issue: 358(3)

Published: March 1, 2025

Abstract Nowadays, diseases have a high rate of incidence and mortality worldwide. On the other side, drawbacks conventional modalities in suppression encountered serious problematic issues for health human beings. For instance, although various approaches been applied treatment cancer, it has an ever‐increasing throughout globe. Thus, there is fundamental requirement development breakthrough technologies inhibition diseases. Hyaluronic acid (HA) one most practical biopolymers HA lots potential physicochemical (like rheological, structural, molecular weight, ionization, etc.) biomedical properties (bioavailability, biocompatibility, CD44 targeting signaling pathways, components biological organs, mucoadhesion, immunomodulation, etc.), which made candidate tools pharmaceutical sciences. The ease surface modification (carboxylation, amidation, hydroxylation, esterification), bioavailability synthesis routes, administration routes are considered as merits HA‐based vehicles. These mucopolysaccharide materials considerably developed use drug delivery systems (DDSs), cancer therapy, wound healing, antiaging, tissue engineering. This review summarizes advantages DDS scaffolds

Language: Английский

Citations

0

Recent advances in stimuli-responsive hyaluronic acid-based nanodelivery systems for cancer treatment: A review DOI
Mengdi Wu, Jun Sheng, Qing Xie

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144357 - 144357

Published: May 1, 2025

Language: Английский

Citations

0

Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy DOI Open Access
Muhammad Sarfraz,

Abida Khan,

Gaber El‐Saber Batiha

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(16), P. 4194 - 4194

Published: Aug. 21, 2023

Mangiferin (MGF), a xanthone derived from Mangifera indica L., initially employed as nutraceutical, is now being explored extensively for its anticancer potential. Scientists across the globe have this bioactive managing variety of cancers using validated in vitro and vivo models. The potential biomolecule on well-established breast cancer cell lines such MDA-MB-23, BEAS-2B cells MCF-7 closer to many approved synthetic agents. However, solubility bioavailability are main challenges, oral reported be less than 2%, aqueous also 0.111 mg/mL. Nano-drug delivery systems attempted deliver drugs at desired site rate amounts. Many researchers various nanotechnology-based approaches provide effective safe mangiferin therapy. Nanoparticles were used carriers encapsulate mangiferin, protecting it degradation facilitating cells. They enhance bioavailability, safety efficacy very drug approaches. present review focuses origin structure elucidation derivatives benefits bioactive. offers insight into delivery-related challenges applications nanosized forms against cancer. use relatively new deep-learning approach solve pharmacokinetic issues has been discussed. critically analyzes future hope therapeutic agent management.

Language: Английский

Citations

6

Physicochemical Properties and Release Study of Antimetabolite-Incorporated Stearoyl Chitosan DOI Creative Commons
Anita Marlina, Misni Misran

ACS Omega, Journal Year: 2023, Volume and Issue: 8(43), P. 40494 - 40507

Published: Oct. 20, 2023

Stearoyl chitosan (SC), derived from the acylation of chitosan, contributes to efficiency drug delivery systems because its structure, which accommodates in a particle. Nonetheless, role chemotherapy has been largely unexplored. The present study involves synthesis stearoyl through reaction depolymerized with chloride under mild conditions. resulting compound was subjected structural analysis utilizing Fourier-transform infrared (FTIR) spectroscopy, 1H NMR, and X-ray diffraction (XRD) spectroscopy. dispersion SC molecules phosphate-buffered saline (PBS) forms nanoparticles. best solution achieved at 1:60 chitosan-to-stearoyl weight ratio. Three antimetabolite drugs, methotrexate, pemetrexed, raltitrexed, were selected examine loading efficacy SC. Pemetrexed had highest drug-loading value 36.8% among three antimetabolites incorporated into SC, along an encapsulation 85.1%. size loaded ranged 225 369 nm, their spherical form verified via transmission electron microscope. vitro release showed that demonstrated controlled release, suggesting nanoparticles have significant promise as strategy for chemotherapy.

Language: Английский

Citations

4